Study of the expression levels of Hepatocyte nuclear factor 4 alpha and 3 beta in patients with different outcome of HBV infection

Virology Journal

Volumn 9, Issue , 2012, Pages

  Chen, En Qiang ^a,b   Sun, Hui ^a,b,c   Feng, Ping ^a,b   Gong, Dao Yin ^b   Liu, Cong ^a,b   Bai, Lang ^a,b   Yang, Wen Bing ^a,b   Lei, Xue Zhong ^a,b   Chen, Li Yu ^a,b   Huang, Fei Jun ^b   Tang, Hong ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

Author keywords

Chronic hepatitis B; Hepatocyte nuclear factor 3 beta; Hepatocyte nuclear factor 4 alpha; Immunohistochemistry; Liver cirrhosis; Severe hepatitis B

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 3BETA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HEPATOCYTE NUCLEAR FACTOR 4;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; MALE; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; BIOPSY; BIOSYNTHESIS; GENE EXPRESSION; HOSPITALIZATION; MIDDLE AGED; PATHOGENICITY; PATHOLOGY; VIROLOGY;

HEPATITIS B VIRUS;

ADULT; BIOPSY; FEMALE; GENE EXPRESSION; HEPATITIS B; HEPATITIS B VIRUS; HEPATOCYTE NUCLEAR FACTOR 3-BETA; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 84855864378     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-23     Document Type: Article

References (20)

1. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Lavanchy D, J Viral Hepat 2004 11 97 107 10.1046/j.1365-2893.2003.00487.x 14996343 (Pubitemid 38365759)
2. Hepatitis B virus: significance of naturally occurring mutants. Blum HE, Intervirology 1993 35 40 50 8407249 (Pubitemid 23241057)
3. Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption. Marcellin P, Pequignot F, Delarocque-Astagneau E, Zarski JP, Ganne N, Hillon P, Antona D, Bovet M, Mechain M, Asselah T, Desenclos JC, Jougla E, J Hepatol 2008 48 200 207 10.1016/j.jhep.2007.09.010 18086507
4. Viral factors and outcomes of chronic HBV infection. Huang Y, Lok AS, Am J Gastroenterol 2011 106 93 95 10.1038/ajg.2010.404 21212756
5. Epidemiology and clinical outcomes of hepatitis B virus infection among refugees seen at a U.S. travel medicine clinic: 2005-2008. Museru O, Franco-Paredes C, Travel Med Infect Dis 2009 7 171 174 10.1016/j.tmaid.2009.01. 008 19411045
6. Natural history of hepatitis B virus infection: an update for clinicians. Pungpapong S, Kim WR, Poterucha JJ, Mayo Clin Proc 2007 82 967 975 10.4065/82.8.967 17673066 (Pubitemid 47206372)
7. Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase. Hui CK, Leung N, Yuen ST, Zhang HY, Leung KW, Lu L, Cheung SK, Wong WM, Lau GK, Hepatology 2007 46 395 401 17628874 (Pubitemid 47344774)
8. Natural History and Clinical Consequences of Hepatitis B Virus Infection. Pan CQ, Zhang JX, Int J Med Sci 2005 2 36 40 15968338 (Pubitemid 40944951)
9. Hepatitis B virus transcription and replication. Tang H, Banks KE, Anderson AL, McLachlan A, Drug News Perspect 2001 14 325 334 12813595 (Pubitemid 32970829)
10. Transcription factors in liver development, differentiation, and regeneration. Costa RH, Kalinichenko VV, Holterman AX, Wang X, Hepatology 2003 38 1331 1347 14647040 (Pubitemid 37466956)
11. The correlation of hepatocyte nuclear factor 4 alpha and 3 beta with hepatitis B virus replication in the liver of chronic hepatitis B patients. Long Y, Chen E, Liu C, Huang F, Zhou T, He F, Liu L, Liu F, Tang H, J Viral Hepat 2009 16 537 546 10.1111/j.1365-2893.2009.01089.x 19302415
12. Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism. Tang H, McLachlan A, Proc Natl Acad Sci USA 2001 98 1841 1846 10.1073/pnas.041479698 11172038 (Pubitemid 32165585)
13. Expression profile analysis of the inflammatory response regulated by hepatocyte nuclear factor 4alpha. Wang Z, Bishop EP, Burke PA, BMC Genomics 2011 12 128 10.1186/1471-2164-12-128 21352552
14. Hepatocyte nuclear factor 4 response to injury involves a rapid decrease in DNA binding and transactivation via a JAK2 signal transduction pathway. Li X, Salisbury-Rowswell J, Murdock AD, Forse RA, Burke PA, Biochem J 2002 368 203 211 10.1042/BJ20020233 12106016 (Pubitemid 35463423)
15. Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis through Bax. Liang X, Liu Y, Zhang Q, Gao L, Han L, Ma C, Zhang L, Chen YH, Sun W, J Immunol 2007 178 503 510 17182590 (Pubitemid 46033634)
16. Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1/death receptor 4 expression. Janssen HL, Higuchi H, Abdulkarim A, Gores GJ, J Hepatol 2003 39 414 420 10.1016/S0168-8278(03)00265-4 12927928 (Pubitemid 37070259)
17. Mechanisms of inhibition of nuclear hormone receptor-dependent hepatitis B virus replication by hepatocyte nuclear factor 3beta. Tang H, McLachlan A, J Virol 2002 76 8572 8581 10.1128/JVI.76.17.8572-8581.2002 12163577 (Pubitemid 34864052)
18. Hepatocyte nuclear factor 3beta inhibits hepatitis B virus replication in vivo. Banks KE, Anderson AL, Tang H, Hughes DE, Costa RH, McLachlan A, J Virol 2002 76 12974 12980 10.1128/JVI.76.24.12974-12980.2002 12438623 (Pubitemid 35386981)
19. Induction of prothrombinase fgl2 by the nucleocapsid protein of virulent mouse hepatitis virus is dependent on host hepatic nuclear factor-4 alpha. Ning Q, Lakatoo S, Liu M, Yang W, Wang Z, Phillips MJ, Levy GA, J Biol Chem 2003 278 15541 15549 10.1074/jbc.M212806200 12594208 (Pubitemid 36799661)
20. Replication of the wild type and a natural hepatitis B virus nucleocapsid promoter variant is differentially regulated by nuclear hormone receptors in cell culture. Tang H, Raney AK, McLachlan A, J Virol 2001 75 8937 8948 10.1128/JVI.75.19.8937-8948.2001 11533157 (Pubitemid 32851898)